N, N′ -methyleno-didemnin A from the ascidian trididemnum solidum. Complete NMR assignments and confirmation of the imidazolidinone ring by strategic analysis of 1 J CH

Journal of Natural Products

Volumn 74, Issue 4, 2011, Pages 882-887

  Molinski, Tadeusz F ^a,b   Ko, Jaeyoung ^a   Reynolds, Kirk A ^a   Lievens, Sarah C ^c   Skarda, Katrina R ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDEMNIN A; IMIDAZOLE DERIVATIVE; ANTINEOPLASTIC AGENT; DEPSIPEPTIDE; DIDEMNINS; N,N' METHYLENO DIDEMNIN A; N,N'-METHYLENO-DIDEMNIN A;

ARTICLE; ASCIDIACEA; CONTROLLED STUDY; DRUG STRUCTURE; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; NUCLEAR MAGNETIC RESONANCE; TRIDIDEMNUM SOLIDUM; ANIMAL; CELL STRAIN HCT116; CENTRAL AMERICA; CHEMICAL STRUCTURE; CHEMISTRY; DRUG SCREENING; ISOLATION AND PURIFICATION; UROCHORDATA;

ASCIDIA; TRIDIDEMNUM SOLIDUM;

ANIMALS; ANTINEOPLASTIC AGENTS; CARIBBEAN REGION; DEPSIPEPTIDES; DRUG SCREENING ASSAYS, ANTITUMOR; HCT116 CELLS; HUMANS; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; UROCHORDATA;

EID: 79955424846     PISSN: 01633864     EISSN: 15206025     Source Type: Journal    
DOI: 10.1021/np100846s     Document Type: Article

References (29)

1. Rinehart, K. L., Jr.; Glœr, J. B.; Cook, J. C., Jr.; Mizsak, S. A.; Scahill, T. A. J. Am. Chem. Soc. 1981, 103, 1857-1859
2. Sakai, R.; Stroh, J. G.; Sullins, D. W.; Rinehart, K. L. J. Am. Chem. Soc. 1995, 117, 3734-3748
3. Rinehart, K. L. U.S. Patent 5,294,603, Mar 15, 1994.
4. Rinehart, K. L.; Lithgow-Bertelloni, A. M. Novel Antiviral and Cytotoxic Agent. PCT Int. Pat. Appl. WO 91.04985, Apr 18, 1991.
5. Molinski, T. F.; Dalisay, D. S.; Lievens, S. L.; Saludes, J. P. Nat. Rev. Drug Discovery 2009, 8, 69-85
6. Chun, H. G.; Davies, B.; Hoth, D.; Suffness, M.; Plowman, J.; Flora, K.; Grieshaber, C.; Leyland-Jones, B. Invest. New Drugs 1986, 4, 279-284
7. Rinehart, K. Med. Res. Rev. 2003, 1, 1-27
8. Jimeno, J.; Lopez-Martin, J. A.; Ruiz-Casado, A.; Izquierdo, M. A.; Scheuer, P. J.; Rinehart, K. Anticancer Drugs 2004, 15, 321-329
9. Vera, M. D.; Joullie, M. M. Med. Res. Rev. 2002, 22, 102-145
10. Shin, D. M.; Holoye, P. Y.; Murphy, W. K.; Forman, A.; Papasozomenos, S. C.; Hong, W. K.; Raber, M. Cancer Chemother. Pharmacol. 1991, 29, 145-149
11. Benvenuto, J. A.; Newman, R. A.; Bignami, G. S.; Raybould, T. J.; Raber, M. N.; Esparza, L.; Walters, R. S. Invest. New Drugs 1992, 10, 113-117
12. Kucuk, O.; Young, M. L.; Habermann, T. M.; Wolf, B. C.; Jimeno, J.; Cassileth, P. A. Am. J. Clin. Oncol. 2000, 23, 273-277
13. Lievens, S. C. Structure Elucidation and Configuration of the Sagittamides: Addressing Complex Acyclic Stereochemistry by a Progressive-Convergent Approach. Ph.D. Thesis, University of California, Davis, 2006, pp 55 - 60.
14. McKee, T. C.; Ireland, C. M.; Lindquist, N.; Fenical, W. Tetrahedron Lett. 1989, 30, 3053-3056
15. The conditions of isolation of 4 likely render the imidazolidinone ring as the HCl salt; however, 5 - 8 were isolated as their free bases.
16. 4 J (H64α-H58) = 1.2 Hz. See also ref 15.
17. Glœr, J. B., Ph.D. Thesis, Structures of the Didemnins. University of Illinois, Urbana, 1983.
18. Molinski, T. F.; Ireland, C. M. J. Org. Chem. 1989, 54, 4256-4259
19. Bock, K.; Lundt, I.; Pedersen, C. Tetrahedron Lett. 1973, 1037-1040
20. Pretsch, E.; Bühlmann, P.; Badertscher, M. Structure Determination of Organic Compounds. Tables of Spectra Data, 4 th ed.; Springer: Heidelberg, 2009; p 149.
21. Lee, G. M.; Molinski, T. F. Tetrahedron Lett. 1992, 33, 7671-7674
22. von Pfanz, H.; Kirchner, G. Liebigs Ann. Chem. 1958, 614, 149-158
23. Gesson, J. P.; Jacquesy, J. C.; Mondon, M. Synlett 1990, 669-670
24. BX 0 Hz.
25. Carbinolamines that are formally derived as adducts of peptides with formaldehyde would be expected to show pseudomolecular ions in their MS spectra that are higher by 30 amu mass units, but- as we observed for 7 - their lability under ESIMS ionization conditions is misleading. The reactive formaldehyde equivalent is easily lost, probably in the heated capillary of the ionization stage, and the expected pseudomolecular ions are absent or replaced by different product ions.
26. Molinski, T. F. Nat. Prod. Rep. 2010, 27, 321-329
27. Dalisay, D. S.; Molinski, T. F. J. Nat. Prod. 2009, 72, 739-744
28. Molinski, T. F. Curr. Opin. Biotechnol. 2010, 21, 819-826
29. +).